Kinin-induced prolongation of action-potential duration in right ventricular muscle from rat: Involvement of B1 and B2 receptors

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 2, 1996, Pages 337-343

  Gouin, L ^a   Cardinal, Rene ^a   Adam, A ^a   Drapeau, G ^b   Nadeau, R ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Bradykinin; Carboxypeptidase inhibitor; Kinin agonists and antagonists; Kinin receptors; Rat heart; Ventricular action potential

Indexed keywords

3 (2 GUANIDINOETHYLTHIO) 2 (MERCAPTOMETHYL)PROPIONIC ACID; ANTIARRHYTHMIC AGENT; BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR AGONIST; BRADYKININ[1-8]; CAPTOPRIL; ICATIBANT; KININ; KININASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HEART MUSCLE POTENTIAL; HEART PROTECTION; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE ARRHYTHMIA; MICROELECTRODE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING;

3-MERCAPTOPROPIONIC ACID; ACTION POTENTIALS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BRADYKININ; CAPTOPRIL; ELECTROPHYSIOLOGY; HEART VENTRICLES; KININS; PROTEASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, BRADYKININ; VENTRICULAR FUNCTION, RIGHT;

EID: 0029744864     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199608000-00023     Document Type: Article

References (48)

1. Tobé TJM, de Langen CDJ, Tio RA, Bel KJ, Mook PH, Wesseling H. Effects of bradykinin on inducible sustained ventricular tachycardia two weeks after myocardial infarction in pigs. J Cardiovasc Pharmacol 1991;17:701-6.
2. Vegh A, Szekeres L, Parratt JR. Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs. Br J Pharmacol 1991;104:294-5.
3. Linz W, Schölkens BA. Influence of local converting enzyme inhibition on angiotensin and bradykinin effects in ischemic rat hearts. J Cardiovasc Pharmacol 1987;10(suppl 7):S75-82.
4. 1 receptor. Br J Pharmacol 1993; 108:318-22.
5. Ribuot C, Cardinal R, Gouin L, et al. Prolongation by captopril of action potential duration in the normal and hypertrophied rat ventricle: direct action or inhibition of the local angiotensin converting enzyme? Cardiovasc Res 1994;28: 221-7.
6. Regoli D, Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980;32:1-46.
7. Hall JM. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol Ther 1992;56:131-90.
8. Regoli D, Marceau F, Barabé J. De novo formation of vascular receptors for bradykinin. Can J Physiol Pharmacol 1978;56:674-7.
9. 1 receptors. Eur J Pharmacol 1986;130:11-18.
10. 9-bradykinin to relax rabbit isolated mesenteric arteries is acquired during in vitro incubation. Eur J Pharmacol 1987;142:141-4.
11. 9-bradykinin in vitro and in vivo. Br J Pharmacol 1987;92:257-64.
12. 9-bradykinin in vivo and in vitro. Immunopharmacology 1989;17:187-98.
13. 1 type and their antagonists. In: Burch RM, ed. Bradykinin antagonists: basic and clinical research. New York: Marcel Dekker, 1991: 33-49.
14. 9-bradykinin release following reperfusion on the ischaemic rat heart. Br J Pharmacol 1995;115: 476-8.
15. Hock FJ, Wirth K, Albus U, et al. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol 1991;102:769-73.
16. Wirth K, Hock FJ, Albus U, etal. Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br J Pharmacol 1991;102:774-7.
17. Bao G, Qadri F, Stauss B, Stauss H, Gohlke P, Unger T. HOE 140, a new highly potent and long-acting bradykinin antagonist in conscious rats. Eur J Pharmacol 1991;200:179-́82.
18. 1 receptors for kinins. J Pharmacol Exp Ther 1991 ; 259:997-1003.
19. Plummer TH, Ryan TJ. A potent mercapto byproduct analogue inhibitor for human carboxypeptidase N. Biochem Biophys Res Commun 1981;98:448-54.
20. Regoli D, Drapeau G, Rovero P, et al. Conversion of kinins and their antagonists into B, receptor activators and blockers in isolated vessels. Eur J Pharmacol 1986;127:219-24,
21. 2 receptors. Can J Physiol Pharmacol 1994;72(suppl 2):37.
22. Lambert C, Vermeulen M, Cardinal R, Nadeau R. Effect of the induction of amiodarone biotransformation on ventricular refractory periods in rats. J Pharmacol Exp Ther 1986; 238:307-12.
23. Cardinal R, Sasyniuk BI. Electrophysiological effects of bretylium tosylate on subendocardial purkinje fibers from infarcted canine hearts. J Pharmacol Exp Ther 1978;204: 159-74.
24. Stroobandt R, Brachmann J, Kesteloot H, Kübier W, Senges J. Effect of sotalol, aprindine and the combination aprindine-sotalol on monophasic action potential duration. Eur Heart J 1986;7:47-53.
25. Campbell TJ. Cellular electrophysiological effects of D- and DL-sotalol in guinea-pig sinoatrial node, atrium and ventricle and human atrium: differential tissue sensitivity. Br J Pharmacol 1987;90:593-9.
26. Colatsky TJ. Mechanisms of action of lidocaine and quinidine on action potential duration in rabbit cardiac purkinje fibers: an effect on steady state sodium currents? Circ Res 1982;50:17-27.
27. Quadbeck J, Reiter M. Cardiac action potential and inotropic effect of noradrenaline and calcium. Naunyn Schmiedebergs Arch Pharmacol 1975;286:337-51.
28. Kass RS, Wiegers SE. The ionic basis of concentration-related effects of noradrenaline on the action potential of calf cardiac purkinje fibres. J Physiol 1982;322:541-58.
29. Cohen ML, Kurz KD. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421. J Pharmacol Exp Ther 1982;220:63-9.
30. Yamada H, Fabris B, Allen AM, Jackson B, Johnston CI, Mendelsohn FAO. Localization of angiotensin converting enzyme in rat heart. Circ Res 1991;68:141-9.
31. Fabris B, Jackson B, Cubela R, Mendelsohn FAO, Johnston CI. Angiotensin converting enzyme in the rat heart: studies of its inhibition in vitro and ex vivo. Clin Exp Pharmacol Physiol 1989;16:309-13.
32. Palmieri FE, Bausback HH, Churchill L, Ward PE. Kinin and enkephalin conversion by an endothelial, plasma membrane carboxypeptidase. Biochem Pharmacol 1986;35:2749-56.
33. Skidgel RA, Davis RM, F Tan. Human carboxypeptidase M: purification and characterization of membrane-bound carboxypeptidase that cleaves peptide hormones. J Biol Chem 1989;264:2236-41.
34. Xiong W, Chen LM, Woodley-Miller C, Simson JAV, Chao J. Identification, purification and localization of tissue kallikrein in rat heart. Biochem J 1990:267:639-46.
35. Nolly HL, Saed G, Scicli G, Carretero OA, Scicli AG. The kallikrein-kinin system in cardiac tissue. Agents Actions Suppl 1992;38(Pt 3):62-72.
36. Farmer SG. Biochemical and molecular pharmacology of kinin receptors. Annu Rev Pharmacol Toxicol 1992;32:511-36.
37. 1Adrenoceptor-mediated phosphoinositide breakdown and inotropic response in rat left ventricular papillary muscles. Circ Res 1988;62:8-17.
38. Kaku T, Lakatta E, Filburn C. α-Adrenergic regulation of phosphoinositide metabolism and protein kinase C in isolated cardiac myocytes. Cell Physiol 1991;29:C635-42.
39. Rosen MR, Weiss RM, Danilo P Jr. Effects of alpha adrenergic agonists and blockers on Purkinje fibers transmembrane potentials and automaticity in the dog. J Pharmacol Exp Ther 1984;231:566-71.
40. Vogel SM, Terzic A. α-Adrenergic regulation of action potentials in isolated rat cardiomyocytes. Eur J Pharmacol 1989:164:231-9.
41. Ravens U, WangX-L, Wettwer E. Alpha adrenoceptor stimulation reduces outward currents in rat ventricular myocytes. J Pharmacol Exp Ther 1989;250:364-70.
42. 1,-adrenoceptor stimulation in rat cardiac myocytes. Circ Res 1992;71:673-88.
43. - currents in rat ventricular myocytes. Proc Natl Acad Sci USA 1988;85:8756-60.
44. 1 receptors and development of a cellular model for the investigation of these receptors. Br J Pharmacol 1993;109:1254-62.
45. Schrör K. Role of prostaglandins in the cardiovascular effects of bradykinin and angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol 1992;20(suppl 9):S68-73.
46. Campbell WB. Lipid-derived autacoids: eicosanoids and platelet-activating factor. In: Gilman AG, Rail TW, Nies AS, Taylor P, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Macmillan, 1990:608.
47. Mentz P, Opitz H, Förster W. Action of unsaturated fatty acids and prostaglandins on parameters of excitation and contraction in the guinea pig myocardium. Acta Biol Med Germ 1976;35:1165-6.
48. 2 receptors of vasodepressor responses to intravenously administered kinins in anaesthetized dogs. Br J Pharmacol 1993;110:71-6.